Phase Socle : Lymphomes indolents

Phase Socle : Lymphomes indolents

LNH bas grade-Cours DES phase socle du 18 janvier 2022Подробнее

LNH bas grade-Cours DES phase socle du 18 janvier 2022

Indolent/Skin Only Diagnosis (MF, LyP, CBCL, FMF)Подробнее

Indolent/Skin Only Diagnosis (MF, LyP, CBCL, FMF)

SESSION II : LYMPHOMES INDOLENTSПодробнее

SESSION II : LYMPHOMES INDOLENTS

SESSION II : LYMPHOMES INDOLENTSПодробнее

SESSION II : LYMPHOMES INDOLENTS

Phase socle : Lymphome B agressifsПодробнее

Phase socle : Lymphome B agressifs

CUTANEOUS LYMPHOMAS: DIAGNOSIS AND STAGINGПодробнее

CUTANEOUS LYMPHOMAS: DIAGNOSIS AND STAGING

Phase Socle : Immunothérapie dans les hémopathies lymphoïdesПодробнее

Phase Socle : Immunothérapie dans les hémopathies lymphoïdes

Phase socle 2022-2023 : lymphomes B agressifs - Louise ROULINПодробнее

Phase socle 2022-2023 : lymphomes B agressifs - Louise ROULIN

Lymphoma Treatment and EvolutionПодробнее

Lymphoma Treatment and Evolution

Phase Socle : Lymphome de HodgkinПодробнее

Phase Socle : Lymphome de Hodgkin

Elucidating the genetic and molecular basis of DLBCLПодробнее

Elucidating the genetic and molecular basis of DLBCL

Tumor-associated HEVs mediate lymphocyte entry into tumors during cancer immunotherapyПодробнее

Tumor-associated HEVs mediate lymphocyte entry into tumors during cancer immunotherapy

Cytosolic LPS activates caspase-11 pathway – Video abstract [ID 57976]Подробнее

Cytosolic LPS activates caspase-11 pathway – Video abstract [ID 57976]

Osimertinib for EGFR T790M Resistance Mutations in NSCLCПодробнее

Osimertinib for EGFR T790M Resistance Mutations in NSCLC

Novel Genetics and Diagnostic Criteria: Multiforme No More - Meghan Driscoll, MDПодробнее

Novel Genetics and Diagnostic Criteria: Multiforme No More - Meghan Driscoll, MD

The Dichotomy of the Lymph NodeПодробнее

The Dichotomy of the Lymph Node

Acquired Resistance to Osimertinib in T790M-Positive NSCLCПодробнее

Acquired Resistance to Osimertinib in T790M-Positive NSCLC